Espidec SRL
3.3 FTEThe score of Espidec shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +59 % Total assets +9 % Headcount (avg FTE) -31 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Espidec's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 11 Jun 2026
- Year ended 31 Dec 2024filed on 23 Jun 2025
- Year ended 31 Dec 2023filed on 20 Jun 2024
- Year ended 31 Dec 2022filed on 20 Jun 2023
- Year ended 31 Dec 2021filed on 15 Jun 2022
Espidec's financial analysis
- Solvency60.0%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Espidec
Espidec's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0896.802.612
- VAT number
- BE0896802612
- Peppol
- Registered · 0208:0896802612 · as of 01 Nov 2026
- Legal form
- SRL
- Incorporated
- 31 Mar 2008
- Registered office
- 1640 Sint-Genesius-Rode
- Size
- Micro · 3.3 FTE
- Latest accounts
- 2025 · filed on 11 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Espidec (SRL) has been based in Sint-Genesius-Rode since 2008, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 227,994 € and equity of €1.38m; its revenue is not published. With 3.3 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 60.0%, above the median of its sector (44.2%).
Companies similar to Espidec
Companies in the same business, of comparable size and area, outside its group.
- Apotheek Michiels Retail sale of pharmaceutical products Zoersel · balance sheet €2.29m
- De Munter - De Waele Retail sale of pharmaceutical products Laarne · balance sheet €2.32m
- Holsbeek Schilde Retail sale of pharmaceutical products Schilde · balance sheet €2.33m
- Kristof Beheyt Retail sale of pharmaceutical products Maldegem · balance sheet €2.34m
- Hoffmann Apotheek Retail sale of pharmaceutical products Keerbergen · balance sheet €2.34m
- Pharmacerto Retail sale of pharmaceutical products Sint-Niklaas · balance sheet €2.34m
- F. Rodenbach Retail sale of pharmaceutical products Zulte · balance sheet €2.25m
- Pharma Guillaume Retail sale of pharmaceutical products Ciney · balance sheet €2.35m
Frequently asked questions about Espidec
What is the revenue of Espidec?
Espidec files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Espidec?
In Belgium, the VAT number is the company number prefixed with BE: BE0896802612 for Espidec, if the company is VAT-registered. Its company number (CBE) is 0896.802.612.
Where is the registered office of Espidec?
According to the CBE register, the registered office of Espidec is in 1640 Sint-Genesius-Rode.
What is the equity of Espidec?
At the close of the 2025 financial year, the equity of Espidec amounts to 1,379,391 €, a solvency of 60.0% of total assets.
How many people work at Espidec?
3.3 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Espidec?
The register lists 2 active mandates at Espidec. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Espidec
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →